Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine in Advanced Colorectal Cancer
NCT00007943Phase 2Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Sep 2000
- Primary completion
- Feb 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in colorectal cancer (CRC), sponsored by Wake Forest University Health Sciences. Started Sep 2000; status: completed.
02
Drugs
gemcitabine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00007943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007943.